Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00454779
What this trial is testing

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
Amgen 113
Testing effectiveness (Phase 2)Ended earlyNCT02196168
What this trial is testing

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more
National Cancer Institute (NCI) 6
Large-scale testing (Phase 3)Looking for participantsNCT06123884
What this trial is testing

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Who this might be right for
Cervical Cancer
Bio-Thera Solutions 526
Testing effectiveness (Phase 2)UnknownNCT00905658
What this trial is testing

Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+4 more
Centre Oscar Lambret 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686926
What this trial is testing

Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172217
What this trial is testing

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

Who this might be right for
Recurrent Cervical Cancer
Qilu Hospital of Shandong University 33
Testing effectiveness (Phase 2)Study completedNCT00259402
What this trial is testing

Oxaliplatin in Esophagus Cancer (Advanced) 1st Line

Who this might be right for
Esophageal Neoplasms
Sanofi 41
Early research (Phase 1)Study completedNCT02645864
What this trial is testing

Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 12
Large-scale testing (Phase 3)UnknownNCT03912415
What this trial is testing

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)

Who this might be right for
Cervical Cancer
Biocad 316
Testing effectiveness (Phase 2)Study completedNCT04996758
What this trial is testing

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT00209690
What this trial is testing

Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Hokkaido Gastrointestinal Cancer Study Group 30
Testing effectiveness (Phase 2)WithdrawnNCT03390738
What this trial is testing

Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
The University of Hong Kong
Testing effectiveness (Phase 2)Active Not RecruitingNCT05172258
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+12 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT04697628
What this trial is testing

Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Seagen, a wholly owned subsidiary of Pfizer 502
Large-scale testing (Phase 3)Ended earlyNCT04458909
What this trial is testing

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Keratinizing Squamous Cell CarcinomaMetastatic Nasopharyngeal Nonkeratinizing Carcinoma+8 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT00816634
What this trial is testing

Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
First Line ChemotherapyCapecitabine Plus Cisplatin Versus Capecitabine Plus PaclitaxelAdvanced or Recurrent Esophageal Squamous Cell Carcinoma
Samsung Medical Center 94
Not applicableStudy completedNCT04870008
What this trial is testing

Aesthetic Outcome of Running Cuticular Suture Distance (2mm vs 5mm)

Who this might be right for
SutureDermatologic SurgeryScar+1 more
University of California, Davis 50
Large-scale testing (Phase 3)WithdrawnNCT01998347
What this trial is testing

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shantou University Medical College
Large-scale testing (Phase 3)Study completedNCT02853474
What this trial is testing

Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

Who this might be right for
Gastric CancerPancreas CancerBile Duct Cancer+2 more
Centre Oscar Lambret 480
Testing effectiveness (Phase 2)UnknownNCT02016274
What this trial is testing

Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Cancer
Shen Lin 70
Next Page
52